Evidence-based diagnosis

Evidence-Based Diagnosis

Volumn , Issue , 2009, Pages 1-295

  Newman, Thomas B ^a   Kohn, Michael A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925163651     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511759512     Document Type: Book

References (238)

1. Evidence-Based Medicine Working Group (1992). “Evidence-based medicine. A new approach to teaching the practice of medicine.” JAMA 268(17): 2420-5.
2. Kohn, M. A., K. Kerr, et al. (2003). “Beta-human chorionic gonadotropin levels and the likelihood of ectopic pregnancy in emergency department patients with abdominal pain or vaginal bleeding.” Acad Emerg Med 10(2): 119-26.
3. Lee, T. H., and L. Goldman (2000). “Evaluation of the patient with acute chest pain.” N Engl J Med 342(16): 1187-95.
4. AAP (1999). “Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection.” Pediatrics 103(4 Pt 1): 843-52.
5. Campbell, J. P. (1989). “Dietary treatment of infant colic: a double-blind study.” JR Coll Gen Pract 39(318): 11-4.
6. Forsyth, B. W. (1989). “Colic and the effect of changing formulas: a double-blind, multiple- crossover study.” JPediatr 115(4): 521-6.
7. Garin, E. H., F. Olavarria, et al. (2006). “Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study.” Pediatrics 117(3): 626-32.
8. Hodson, E. M., D. M. Wheeler, et al. (2007). “Interventions for primary vesicoureteric reflux.” Cochrane Database Syst Rev 3: CD001532.
9. Lucassen, P. L., W. J. Assendelft, et al. (2000). “Infantile colic: crying time reduction with a whey hydrolysate: a double-blind, randomized, placebo-controlled trial.” Pediatrics 106(6): 1349-54.
10. Newman, T. B. (2006). “Much pain, little gain from voiding cystourethrograms after urinary tract infection.” Pediatrics 118(5): 2251.
11. Altman, D. G. (1991). Practical Statistics for Medical Research. London, Chapman and Hall.
12. Bland, J. M., and D. G. Altman (1986). “Statistical methods for assessing agreement between two methods of clinical measurement.” Lancet 1(8476): 307-10.
13. Bland, J. M., and D. G. Altman (1996a). “Measurement error.” Br Med J 313(7059): 744.
14. Bland, J. M., and D. G. Altman (1996b). “Measurement error and correlation coefficients.” Br Med J 313(7048): 41-2.
15. Bland, J. M., and D. G. Altman (1999). “Measuring agreement in method comparison studies.” Stat Methods Med Res 8(2): 135-60.
16. Bos, W. J., J. van Goudoever, et al. (1996). “Reconstruction of brachial artery pressure from noninvasive finger pressure measurements.” Circulation 94(8): 1870-5.
17. Feinstein, A. R., and D. V. Cicchetti (1990). “High agreement but low kappa. I. The problems of two paradoxes.” J Clin Epidemiol 43(6): 543-9.
18. Gill, M. R., D. G. Reiley, et al. (2004). “Interrater reliability of Glasgow Coma Scale scores in the emergency department.” Ann Emerg Med 43(2): 215-23.
19. Krouwer, J. S. (2008). “Why Bland-Altman plots should use X, not (Y + X)/2 when X is a reference method.” Stat Med 27(5): 778-80.
20. Lederle, F. A., S. E. Wilson, et al. (1995). “Variability in measurement of abdominal aortic aneurysms. Abdominal Aortic Aneurysm Detection and Management Veterans Administration Cooperative Study Group.” JVasc Surg 21(6): 945-52.
21. Meyer, B. C., T. M. Hemmen, et al. (2002). “Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity.” Stroke 33(5): 1261-6.
22. Newman, T. B., W. S. Browner, et al. (2007). “Designing Studies of Medical Tests” in Designing Clinical Research. S. B. Hulley, et al. Philadelphia, PA, Lippincott Williams & Wilkins.
23. Sackett, D., R. Haynes, et al. (1991). Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston, Little, Brown and Company.
24. Wren, T. A., X. Liu, et al. (2005). “Bone densitometry in pediatric populations: discrepancies in the diagnosis of osteoporosis by DXA and CT.” J Pediatr 146(6): 776-9.
25. Yen, K., A. Karpas, et al. (2005). “Interexaminer reliability in physical examination of pediatric patients with abdominal pain.” Arch Pediatr Adolesc Med 159(4): 373-6.
26. Gill, M. R., D. G. Reiley, et al. (2004). “Interrater reliability of Glasgow Coma Scale scores in the emergency department.” Ann Emerg Med 43(2): 215-23.
27. Sinal, S. H., M. R. Lawless, et al. (1997). “Clinician agreement on physical findings in child sexual abuse cases.” Arch Pediatr Adolesc Med 151(5): 497-501.
28. Sprouse, L. R., 2nd, G. H. Meier 3rd, et al. (2003). “Comparison of abdominal aortic aneurysm diameter measurements obtained with ultrasound and computed tomography: Is there a difference?” J Vasc Surg 38(3): 466-71; discussion 471-2.
29. Yen, K., A. Karpas, et al. (2005). “Interexaminer reliability in physical examination of pediatric patients with abdominal pain.” Arch Pediatr Adolesc Med 159(4):373-6
30. Detsky, A. S., G. Naglie, et al. (1997a). “Primer on medical decision analysis: Part 1. Getting started.” Med Decis Making 17(2): 123-5.
31. Detsky, A. S., G. Naglie, et al. (1997b). “Primer on medical decision analysis: Part 2. Building a tree.” Med Decis Making 17(2): 126-35.
32. Hilden, J., and P. Glasziou (1996). “Regret graphs, diagnostic uncertainty and Youden's Index.” Stat Med 15(10): 969-86.
33. Kerlikowske, K., D. Grady, et al. (1996a). “Effect of age, breast density, and family history on the sensitivity of first screening mammography.” JAMA 276(1): 33-8.
34. Kerlikowske, K., D. Grady, et al. (1996b). “Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation.” JAMA 276(1): 39-43.
35. Krahn, M. D., G. Naglie, et al. (1997). “Primer on medical decision analysis: Part 4. Analyzing the model and interpreting the results.” Med Decis Making 17(2): 142-51.
36. Naglie, G., M. D. Krahn, et al. (1997). “Primer on medical decision analysis: Part 3. Estimating probabilities and utilities.” Med Decis Making 17(2): 136-41.
37. Naimark, D., M. D. Krahn, et al. (1997). “Primer on medical decision analysis: Part 5. Working with Markov processes.” Med Decis Making 17(2): 152-9.
38. Newman, T. B., J. A. Bernzweig, et al. (2002). “Urine testing and urinary tract infections in febrile infants seen in office settings: the Pediatric Research in Office Settings’ Febrile Infant Study.” Arch Pediatr Adolesc Med 156(1): 44-54.
39. Pauker, S. G., and J. P. Kassirer (1975). “Therapeutic decision making: A cost-benefit analysis.” N Engl J Med 293(5): 229-34.
40. Pauker, S. G., and J. P. Kassirer (1980). “The threshold approach to clinical decision making.” NEngl JMed 302(20): 1109-17.
41. Poehling, K. A., M. R. Griffin, et al. (2002). “Bedside diagnosis of influenzavirus infections in hospitalized children.” Pediatrics 110(1 Pt 1): 83-8.
42. Sox, H. C., Jr. (1986). “Probability theory in the use of diagnostic tests. An introduction to critical study of the literature.” Ann Intern Med 104(1): 60-6.
43. Sox, H. C., M. A. Blatt, et al. (1988). Medical Decision Making. Boston, Butterworths.
44. Gaitan-Cepeda, L. A., M. Martinez-Gonzalez, et al. (2005). “Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART.” AIDS Patient Care STDS 19(2): 70-7.
45. Haydel, M. J., C. A. Preston, et al. (2000). “Indications for computed tomography in patients with minor head injury.” N Engl J Med 343(2): 100-5.
46. Roddey, O. F., Jr., H. W. Clegg, et al. (1995). “Comparison of an optical immunoassay technique with two culture methods for the detection of group A streptococci in a pediatric office.” JPediatr 126(6): 931-3.
47. Zangwill, K. M., D. H. Hamilton, et al. (1993). “Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test.” N Engl J Med 329(1): 8-13.
48. Bonsu, B. K., and M. B. Harper (2003). “Utility of the peripheral blood white blood cell count for identifying sick young infants who need lumbar puncture.” Ann Emerg Med 41(2): 206-14.
49. Hanley, J. A., and B. J. McNeil (1982). “The meaning and use of the area under a receiver operating characteristic (ROC) curve.” Radiology 143(1): 29-36.
50. Kohn, M. A., and M. P. Newman (2001). “What white blood cell count should prompt antibiotic treatment in a febrile child? Tutorial on the importance of disease likelihood to the interpretation of diagnostic tests.” Med Decis Making 21(6): 479-89.
51. Lee, G. M., and M. B. Harper (1998). “Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era.” Arch Pediatr Adolesc Med 152(7): 624-8.
52. PIOPED (1990). “Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED).” JAMA. 263(20): 2753-9.
53. Swets, J. A. (1996). Signal Detection Theory and ROC Analysis in Psychology and Diagnostics: Collected Papers. Mahwah, NJ, L. Erlbaum Associates.
54. Brennan, M. L., M. S. Penn, et al. (2003). “Prognostic value of myeloperoxidase in patients with chest pain.” NEngl J Med 349(17): 1595-604.
55. Cicero, S., G. Rembouskos, et al. (2004). “Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan.” Ultrasound Obstet Gynecol 23(3): 218-23.
56. Maisel, A. S., P. Krishnaswamy, et al. (2002). “Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.” N Engl J Med 347(3): 161-7.
57. Pantell, R. H., T. B. Newman, et al. (2004). “Management and outcomes of care of fever in early infancy.” JAMA 291(10): 1203-12.
58. Nassar, N., C. L. Roberts, et al. (2006). “Diagnostic accuracy of clinical examination for detection of non-cephalic presentation in late pregnancy: cross sectional analytic study.” BrMed J 333(7568): 578-80.
59. Pai, M., M. McCulloch, et al. (2004). “Systematic reviews of diagnostic test evaluations: What's behind the scenes?” ACP J Club 141(1): A11-3.
60. Straus, S., W. Richardson, et al. (2005). Evidence-Based Medicine: How to Practice and Teach EBM. New York, Elsevier/Churchill Livingstone.
61. Wheeler, A. P., G. R. Bernard, et al. (2006). “Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.” N Engl J Med 354(21): 2213-24.
62. Whiting, P., R. Harbord, et al. (2006). “Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review.” Br Med J 332(7546): 875-84.
63. Eshed, I., A. Gorenstein, et al. (2004). “Intussusception in children: can we rely on screening sonography performed by junior residents?” Pediatr Radiol 34(2): 134-7.
64. Maisel, A. S., P. Krishnaswamy, et al. (2002). “Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.” N Engl J Med 347(3): 161-7.
65. Mari, H K. A., T. E Ingmire, et al. (1999). “Utility of a single beta HCG measurement to evaluate for absence of ectopic pregnancy.” J EmergMed 17(3): 419-26.
66. Schwam, E. (2004). “B-type natriuretic peptide for diagnosis of heart failure in emergency department patients: a critical appraisal.” Acad EmergMed 11(6): 686-91.
67. Werner, E. J., T. C. Abshire, et al. (1992). “Relative value of diagnostic studies for von Willebrand disease.” J Pediatr 121(1): 34-8.
68. Barton, M., D. Morley, et al. (2004). “Decreasing women's anxieties after abnormal mammograms: a controlled trial.” J Natl Cancer Inst 96: 529-38.
69. Black, W. C., D. A. Haggstrom, et al. (2002). “All-cause mortality in randomized trials of cancer screening.” J Natl Cancer Inst 94(3): 167-73.
70. Black, W. C., and H. G. Welch (1997). “Screening for disease.” AJRAm J Roentgenol 168(1): 3-11.
71. Braveman, P., and E. Tarimo (1994). Screening in Primary Health Care: Setting Priorities with Limited Resources. Geneva, World Health Organization.
72. Daniels, N. (1986). “Why saying no to patients in the United States is so hard. Cost containment, justice, and provider autonomy.” NEngl JMed 314(21): 1380-3.
73. Early Breast Cancer Trialists’ Collaborative Group (2000). “Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials.” Lancet 355(9217): 1757-70.
74. Eddy, D. (1991). Common Screening Tests. Philadelphia, PA, American College of Physicians.
75. Eddy, D. M. (1997). “Breast cancer screening in women younger than 50 years of age: what's next?” Ann Intern Med 127(11): 1035-6.
76. Epstein, A. E., A. P. Hallstrom, et al. (1993). “Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the Cardiac Arrhythmia Suppression Trial (CAST).” JAMA 270(20): 2451-5.
77. Ernster, V. L. (1997). “Mammography screening for women aged 40 through 49-a guidelines saga and a clarion call for informed decision making.” Am J Public Health 87(7): 1103-6.
78. Feinstein, A. R., D. M. Sosin, et al. (1985). “The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.” N Engl J Med 312(25): 1604-8.
79. Fyro, K., and G. Bodegard (1987). “Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism.” Acta Paediatr Scand 76(1): 107-14.
80. Guyatt, G., D. Rennie, et al. (2008). Users’ Guides to the Medical Literature: A Manual for Evidence- Based Clinical Practice, 2nd Edition. New York, NY, McGraw Hill Medical, pp. 113-143.
81. Haynes, R. B., D. L. Sackett, et al. (1978). “Increased absenteeism from work after detection and labeling of hypertensive patients.” N Engl JMed 299(14): 741-4.
82. HEDIS (2009). “The Health Plan Employer Data and Information Set (HEDIS®).” Available from: http://www.ncqa.org/tabid/784/Default.aspx. Accessed 10/3/08.
83. Herman, C. R., H. K. Gill, et al. (2002). “Screening for preclinical disease: test and disease characteristics.” AJRAm J Roentgenol 179(4): 825-31.
84. Law, J., and K. Faulkner (2001). “Cancers detected and induced, and associated risk and benefit, in a breast screening programme.” Br J Radiol 74(888): 1121-7.
85. Lee, T., and T. Brennan (2002). “Direct-to-consumer marketing of high-technology screening tests.” NEngl JMed 346(7): 529-531.
86. Marantz, P. R. (1990). “Blamingthe victim: the negative consequence of preventive medicine.” Am JPublic Health 80(10): 1186-7.
87. Marcus, P. M., E. J. Bergstralh, et al. (2000). “Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.” J Natl Cancer Inst 92(16): 1308-16.
88. Mariner, W. K. (1995). “Rationing health care and the need for credible scarcity: why Americans can’t say no.” Am JPublic Health 85(10): 1439-45.
89. Moore, T. J. (1995). Deadly Medicine: Why Tens of Thousands of Heart Patients Died in America's Worst Drug Disaster. New York, Simon & Schuster.
90. Newman, T. B. (2003). “The power of stories over statistics.” Br Med J 327(7429): 1424-7.
91. Olivotto, I. A., P. T. Truong, et al. (2003). “Staging reclassification affects breast cancer survival.” JClin Oncol 21(23): 4467-8.
92. Otto, S. J., F. H. Schroder, et al. (2004). “Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?” JMed Screen 11(2): 89-92.
93. Riggs, B. L., S. F. Hodgson, et al. (1990). “Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.” N Engl J Med 322(12): 802-9.
94. Rubin, S. M., and S. R. Cummings (1992). “Results of bone densitometry affect women's decisions about taking measures to prevent fractures.” Ann Intern Med 116(12 Pt 1): 990-5.
95. Schwartz, L. M., S. Woloshin, et al. (2004). “Enthusiasm for cancer screening in the United States.” JAMA 291(1): 71-8.
96. Welch, H. G. (2004). Should I Be Tested for Cancer? Maybe Not, and Here's Why. Berkeley, CA, University of California Press.
97. WHO (1980). “W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrateto lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.” Lancet 2(8191): 379-85.
98. Woodward, W. A., E. A. Strom, et al. (2003). “Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.” J Clin Oncol 21(17): 3244-8.
99. Ashton, H. A., M. J. Buxton, et al. (2002). “The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.” Lancet 360(9345): 1531-9.
100. Henschke, C. I., D. F. Yankelevitz, et al. (2006). “Survival of patients with stage I lung cancer detected on CT screening.” N Engl J Med 355(17): 1763-71.
101. Mastroiacovo, P., R. Bertollini, et al. (1992). “Survival of children with Down syndrome in Italy.” Am J Med Genet 42(2): 208-12.
102. Torres, C. F., S. Rebsamen, et al. (1994). “Surveillance scanning of children with medulloblastoma” N Engl J Med 330(13): 892-5.
103. Hilsenbeck, S. G., G. M. Clark, et al. (1992). “Why do so many prognostic factors fail to pan out?” Breast Cancer Res Treat 22(3): 197-206.
104. Jellema, P., D. A. Van Der Windt, et al. (2007). “Prediction of an unfavourable course of low back pain in general practice: comparison of four instruments.” Br J Gen Pract 57(534): 15-22.
105. Kyzas, P. A., K. T. Loizou, et al. (2005). “Selective reporting biases in cancer prognostic factor studies.” J Natl Cancer Inst 97(14): 1043-55.
106. Mackillop, W. J., and C. F. Quirt (1997). “Measuring the accuracy of prognostic judgments in oncology.” J Clin Epidemiol 50(1): 21-9.
107. Paik, S., S. Shak, et al. (2004). “A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.” N Engl J Med 351(27): 2817-26.
108. Ravdin, P. M., I. A. Siminoff, et al. (1998). “Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy.” J Clin Oncol 16(2): 515-21.
109. SUPPORT (1995). “A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators.” JAMA 274(20): 1591-8.
110. Tanvetyanon, T. (2005). “Molecular prediction of recurrence of breast cancer.” N Engl J Med 352(15): 1605-7; authorreply 1605-7.
111. Webster's unabridged dictionary (2001). New York, Random House Reference.
112. Brown, J. E., C. S. Thomson, et al. (2003). “Bone resorption predicts [0.3k] for skeletal complications in metastatic bone disease.” Br J Cancer 89(11): 2031-7.
113. Fowler, K. B., S. Stagno, et al. (1992). “The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.” N Engl J Med 326(10): 663-7.
114. Greenland, P., L. LaBree, et al. (2004). “Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals.” JAMA 291(2): 210-5.
115. Jellema, P., D. A. Van Der Windt, et al. (2007). “Prediction of an unfavourable course of low back pain in general practice: comparison of four instruments.” Br J Gen Pract 57(534): 15-22.
116. Mackillop, W. J., and C. F. Quirt (1997). “Measuring the accuracy of prognostic judgments in oncology.” J Clin Epidemiol 50(1): 21-9.
117. Pletcher, M. J., J. A. Tice, et al. (2004). “Use of coronary calcification scores to predict coronary heart disease.” JAMA 291(15): 1831-2; author reply 1832-3.
118. Poeta, M. L., J. Manola, et al. (2007). “TP53 mutations and survival in squamous-cell carcinoma of the head and neck.” N Engl J Med 357(25): 2552-61
119. Cicero, S., G. Rembouskos, et al. (2004). “Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11-14-week scan.” Ultrasound Obstet Gynecol 23(3): 218-23.
120. Fine, M. J., T. E. Auble, et al. (1997). “A prediction rule to identify low-risk patients with community-acquired pneumonia [see comments].” N Engl J Med 336(4): 243-50.
121. Goldman, L., E. F. Cook, et al. (1988). “A computer protocol to predict myocardial infarction in emergency department patients with chest pain.” N Engl J Med 318(13): 797-803.
122. Hoffman, J. R., A. B. Wolfson, et al. (1998). “Selective cervical spine radiography in blunt trauma: methodology of the National Emergency X-Radiography Utilization Study (NEXUS) [see comments].” Ann EmergMed 32(4): 461-9.
123. Hoffman, J. R., W. R. Mower, et al. (2000). “Validity of a set of clinical criteria to rule out injury to the cervical spine in patients with blunt trauma. National Emergency X-Radiography Utilization Study Group.” N Engl J Med 343(2): 94-9.
124. Katz, M. H. (1999). Multivariable Analysis: A Practical Guide for Clinicians. Cambridge, Cambridge University Press.
125. Laupacis A., N. Sekar, et al. (1997). “Clinical prediction rules. A review and suggested modifications of methodological standards.” JAMA 277(6): 488-94.
126. Lee, T. H., G. Juarez, et al. (1991). “Ruling out acute myocardial infarction. A prospective multicenter validation of a 12-hour strategy for patients at low risk.” N Engl JMed 324(18): 1239-46.
127. Leroy, S., E. Marc, et al. (2006). “Prediction of vesicoureteral reflux after a first febrile urinary tract infection in children: validation of a clinical decision rule.” Arch Dis Child 91(3): 241-4.
128. Newman, T. B., J. A. Bernzweig, et al. (2002). “Urine testing and urinary tract infections in febrile infants seen in office settings: the Pediatric Research in Office Settings’ Febrile Infant Study.” Arch Pediatr Adolesc Med 156(1): 44-54.
129. Nicolaides, K. H. (2004). The 11-13+6 Weeks Scan. London, Fetal Medicine Foundation.
130. Oostenbrink, R., A. J. Van Der Heijden, et al. (2000). “Prediction of vesico-ureteric reflux in childhood urinary tract infection: a multivariate approach.” Acta Paediatr 89(7): 806-10.
131. Pantell, R. H., T. B. Newman, et al. (2004). “Management and outcomes of care of fever in early infancy.” JAMA 291(10): 1203-12.
132. Quinn, J. V., I. G. Stiell, et al. (2004). “Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes.” Ann EmergMed 43(2): 224-32.
133. Selker, H. P., J. L. Griffith, et al. (1991). “A tool for judging coronary care unit admission appropriateness, valid for both real-time and retrospective use. A time-insensitive predictive instrument (TIPI) for acute cardiac ischemia: a multicenter study.” Med Care 29(7): 610-27. [For corrected coefficients, see http://medg.lcs.mit.edu/cardiac/tipicoef.htm.]
134. Selker, H. P., J. R. Beshansky, et al. (1998). “Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial.” Ann Intern Med 129(11): 845-55.
135. Snijders, R. J., K. Sundberg, et al. (1999). “Maternal age- and gestation-specific risk for trisomy 21.” Ultrasound Obstet Gynecol 13(3): 167-70.
136. Stiell, I. G., R. D. McKnight, et al. (1994). “Implementation of the Ottawa ankle rules.” JAMA 271(11): 827-32.
137. Wasson, J. H., H. C. Sox, et al. (1985). “Clinical prediction rules. Applications and methodological standards.” N Engl J Med 313(13): 793-9.
138. Beiser, A. S., M. Takahashi, et al. (1998). “A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group.” Am J Cardiol 81(9): 1116- 20.
139. Goldman, L., E. F. Cook, et al. (1996). “Prediction of the need for intensive care in patients who come to the emergency departments with acute chest pain.” N Engl J Med 334(23): 1498-504.
140. Kaiser, S., B. Frenckner, etal. (2002). “Suspectedappendicitis in children: US and CT-aprospective randomized study.” Radiology 223(3): 633-8.
141. Kohn, M. A., and M. P. Newman (2001). “What white blood cell count should prompt antibiotic treatment in a febrile child? Tutorial on the importance of disease likelihood to the interpretation of diagnostic tests.” Med Decis Making 21(6): 479-89.
142. Lee, G. M., and M. B. Harper (1998). “Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era.” Arch Pediatr Adolesc Med 152(7): 624-8.
143. Accord Study Group (2008). “Effects of intensive glucose lowering in type 2 diabetes.” N Engl J Med 358(24): 2630-3.
144. ECSSG (1979). “Coronary-artery bypass surgery in stable angina pectoris: Survival at two years. European Coronary Surgery Study Group.” Lancet 1(8122): 889-93.
145. Ferreira-Gonzalez, I., J. W. Busse, et al. (2007). “Problems with use of composite endpoints in cardiovascular trials: systematic review of randomised controlled trials.” Br Med J 334(7597): 786.
146. Goss, P. E., J. N. Ingle, et al. (2003). “A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.” N Engl J Med 349(19): 1793-802.
147. nd ed. Chicago, IL, AMA Press: 119-130.
148. Hollis, S., and F. Campbell (1999). “What is meant by intention to treat analysis? Survey of published randomised controlled trials.” Br Med J 319(7211): 670-4.
149. rd Ed. Philadelphia, PA, Lippincott Williams & Wilkins.
150. ISIS-2 (1988). “Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.” Lancet 2(8607): 349-60.
151. Nissen, S. E., T. Tsunoda, et al. (2003). “Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial.” JAMA 290(17): 2292-300.
152. Russell, S. (2003). Drug cuts risk of breast-cancer relapse. Chronicle. San Francisco, CA. Oct 10, Page l.
153. Tonstad, S., P. Tonnesen, et al. (2006). “Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.” JAMA 296(1): 64-71.
154. Treanor, J. J., F. G. Hayden, et al. (2000). “Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.” JAMA 283(8): 1016-24.
155. Waksman, R., A. E. Ajani, et al. (2002). “Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts.” N Engl J Med 346(16): 1194-9.
156. Welliver, R., A. S. Monto, et al. (2001). “Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.” JAMA 285(6): 748-54.
157. Cantekin, E. I., T. W. McGuire, et al. (1990). “Biomedical information, peer review, and conflict of interest as they influence public health.” JAMA 263(10): 1427-30.
158. Cantekin, E. I., T. W. McGuire, et al. (1991). “Antimicrobial therapy for otitis media with effusion (‘secretory’ otitis media).” JAMA 266(23): 3309-17.
159. GUSTO (1993). “An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators.” N Engl JMed 329(10): 673-82.
160. ISIS-2 (1988). “Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.” Lancet 2(8607): 349-60.
161. Kamm, M. A., S. Muller-Lissner, et al. (2005). “Tegaserod for the treatment of chronic constipation: a randomized, double-blind, placebo-controlled multinational study.” Am J Gastroenterol 100(2): 362-72.
162. Maizels, M., B. Scott, et al. (1996). “Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial.” JAMA 276(4): 319-21.
163. Mandel, E. M., H. E. Rockette, et al. (1987). “Efficacy of amoxicillin with and without decongestant- antihistamine for otitis media with effusion in children. Results of a double-blind, randomized trial.” NEngl JMed 316(8): 432-7.
164. Niederau, C., T. Heintges, et al. (1996). “Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.” N Engl J Med 334(22): 1422-7.
165. Odio, C. M., I. Faingezicht, et al. (1991). “The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis.” N Engl J Med 324(22): 1525-31.
166. Peacock, W. F., J. E. Hollander, et al. (2007). “Reperfusion strategies in the emergency treatment of ST-segment elevation myocardial infarction.” Am JEmergMed 25(3): 353-66.
167. Rennie, D. (1991). “The Cantekin affair.” JAMA 266(23): 3333-7.
168. Bell, C. M., and D. A. Redelmeier (2001). “Mortality among patients admitted to hospitals on weekends as compared with weekdays.” NEngl JMed 345(9): 663-8.
169. Booth, G. L., and J. E. Hux (2003). “Relationship between avoidable hospitalizations for diabetes mellitus and income level.” Arch Intern Med 163(1): 101-6.
170. Cook, T. D., and D. T. Campbell (1979). Quasi-Experimentation: Design & Analysis Issues for Field Settings. Chicago, IL, Rand McNally College Pub. Co.
171. Eidelman, R. S., D. Hollar, et al. (2004). “Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease.” Arch Intern Med 164(14): 1552-6.
172. Gum, P. A., M. Thamilarasan, et al. (2001). “Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis.” JAMA 286(10): 1187-94.
173. Hearst, N., T. B. Newman, et al. (1986). “Delayed effects of the military draft on mortality. A randomized natural experiment.” N Engl J Med 314(10): 620-4.
174. Johnston, S. C. (2000). “Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes.” Stroke 31(1): 111-7.
175. Johnston, S. C., R. A. Dudley, et al. (1999). “Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals.” Neurology 52(9): 1799-805.
176. Katz, M. H. (1999). Multivariable Analysis: A Practical Guide for Clinicians. Cambridge, Cambridge University Press.
177. Miller, E. R., 3rd, R. Pastor-Barriuso, et al. (2005). “Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.” Ann Intern Med 142(1): 37-46.
178. Psaty, B. M., S. R. Heckbert, et al. (1995). “The risk of myocardial infarction associated with antihypertensive drug therapies.” JAMA 274(8): 620-5.
179. Rimm, E. B., M. J. Stampfer, et al. (1993). “Vitamin E consumption and the risk of coronary heart disease in men.” N Engl J Med 328(20): 1450-6.
180. Selby, J. V., G. D. Friedman, et al. (1992). “A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.” N Engl J Med 326(10): 653-7.
181. Stampfer, M. J., C. H. Hennekens, et al. (1993). “Vitamin E consumption and the risk of coronary disease in women.” N Engl J Med 328(20): 1444-9.
182. Turnbull, F., B. Neal, et al. (2005). “Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.” Arch Intern Med 165(12): 1410-9.
183. Warram, J. H., L. M. Laffel, et al. (1991). “Excess mortality associated with diuretic therapy in diabetes mellitus.” Arch Intern Med 151(7): 1350-6.
184. Lindenauer, P. K., P. Pekow, et al. (2004). “Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery.” JAMA 291(17): 2092-9.
185. Nichol, K. L., J. Nordin, et al. (2003). “Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly.” N Engl J Med 348(14): 1322-32.
186. Browner, W. S., and T. B. Newman (1987). “Are all significant P values created equal? The analogy between diagnostic tests and clinical research.” JAMA 257(18): 2459-63.
187. Glantz, S. A. (2002). Primer of Biostatistics. New York, NY, McGraw-Hill, Medical Pub. Div.
188. Goodman, S. N. (1999a). “Toward evidence-based medical statistics. 1: The P value fallacy.” Ann Intern Med 130(12): 995-1004.
189. Goodman, S. N. (1999b). “Toward evidence-based medical statistics. 2: The Bayes factor.” Ann Intern Med 130(12): 1005-13.
190. Goodman, S. N. (2001). “Of P-values and Bayes: a modest proposal.” Epidemiology 12(3): 295-7.
191. Guyatt, G., D. Rennie, et al. (2002). Users’ Guides to the Medical Literature: Essentials of Evidence- Based Clinical Practice. Chicago, IL, AMA Press.
192. Hanley, J. A., and A. Lippman-Hand (1983). “If nothing goes wrong, is everything all right? Interpreting zero numerators.” JAMA 249(13): 1743-5.
193. Jaffe, D. M., R. R. Tanz, et al. (1987). “Antibiotic administration to treat possible occult bacteremia in febrile children.” NEngl J Med 317(19): 1175-80.
194. Newman, T. B. (1995). “If almost nothing goes wrong, is almost everything all right? Interpreting small numerators.” JAMA 274(13): 1013.
195. Newman, T. B., and R. H. Pantell (1988). “Occult bacteremia in febrile children.” N Engl J Med 318(20): 1338-9.
196. Sackett, D. L., R. B. Haynes, et al. (1991). Clinical Epidemiology: A Basic Science for Clinical Medicine. Boston, MA, Little Brown.
197. Sackett, D. L., R. B. Haynes, et al. (2000). Evidence-Based Medicine: How to practice and teach EBM, 2nd Ed. Edinburgh: Churchill Livingstone: 233.
198. Weiss, R., J. Duckett, et al. (1992). “Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children.” J Urol 148(5 Pt 2): 1667-73.
199. Foxman, B., and R. R. Frerichs (1985). “Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse.” Am JPublicHealth 75(11): 1308-13.
200. Keller, M. B., N. D. Ryan, et al. (2001). “Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.” JAm Acad Child Adolesc Psychiatry 40(7): 762-72.
201. Krag, D., and T. Ashikaga (2003). “The design of trials comparing sentinel-node surgery and axillary resection.” N Engl J Med 349(6): 603-5.
202. Veronesi, U., G. Paganelli, et al. (2003). “A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.” N Engl J Med 349(6): 546-53.
203. Armstrong, K., E. Moye, et al. (2007). “Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians.” Ann Intern Med 146(7): 516-26.
204. Bornstein, B. H., and A. C. Emler (2001). “Rationality in medical decision making: a review of the literature on doctors’ decision-making biases.” J Eval Clin Pract 7(2): 97-107.
205. Brewer, N. T., G. B. Chapman, et al. (2007). “The influence of irrelevant anchors on the judgments and choices of doctors and patients.” Med Decis Making 27(2): 203-11.
206. Burt, C. W. (1999). “Summary statistics for acute cardiac ischemia and chest pain visits to United States EDs, 1995-1996.” Am JEmergMed 17(6): 552-9.
207. Cahan, A., D. Gilon, et al. (2003). “Probabilistic reasoning and clinical decision-making: do doctors overestimate diagnostic probabilities?” QJM 96(10): 763-9.
208. Cahan, A., D. Gilon, et al. (2005). “Clinical experience did not reduce the variance in physicians’ estimates of pretest probability in a cross-sectional survey.” J Clin Epidemiol 58(11): 1211-6.
209. Cardall, T., J. Glasser, et al. (2004). “Clinical value of the total white blood cell count and temperature in the evaluation of patients with suspected appendicitis.” Acad Emerg Med 11(10): 1021-7.
210. Croskerry, P. (2002). “Achieving quality in clinical decision making: cognitive strategies and detection of bias.” Acad Emerg Med 9(11): 1184-204.
211. Croskerry, P., and R. Wears (2003). Safety errors in emergency medicine. In: Emergency Medicine Secrets. Markovchik. VJ and Pons. PT. Philadelphia, PA, Hanley and Belfus.
212. Davison, G., A. L. Suchman, et al. (1990). “Reducing unnecessary coronary care unit admissions: a comparison of three decision aids [see comments].” J Gen Intern Med 5(6): 474-9.
213. Dawson, N. V., and H. R. Arkes (1987). “Systematic errors in medical decision making: judgment limitations.” J Gen Intern Med 2(3): 183-7.
214. Detmer, D. E., D. G. Fryback, et al. (1978). “Heuristics and biases in medical decision-making.” JMed Educ 53(8): 682-3.
215. Dolan, J. G., D. R. Bordley, et al. (1986). “An evaluation of clinicians’ subjective prior probability estimates.” Med Decis Making 6(4): 216-23.
216. Eddy, D. M. (1982). Probabilistic reasoning in clinical medicine: problems and opportunities. In: Judgment Under Uncertainty: Heuristics and Biases. D. Kahneman, P. Slovic, and A. Tversky, editors. Cambridge, Cambridge University Press, pp. 249-267.
217. Gorman, C. (2007). “Are Doctors Just Playing Hunches?” Time Magazine. February 15, 2007.
218. Groopman, J. (2007). How Doctors Think. New York: Houghton Mifflin.
219. Grahame-Smith, D. (1995). “Evidence based medicine: Socratic dissent [see comments].” Br Med J 310(6987): 1126-7.
220. Hayward, R. (2008). “Access to clinically-detailed patient information.” Med Care 46(3): 229.
221. Healy, B. (2006). “Who Says What's Best?” U.S. News and World Report.
222. Humphrey, L. L., M. Helfand, et al. (2002). “Breast cancer screening: a summary of the evidence forthe U.S. Preventive Services Task Force.” Ann Intern Med 137(5 Part 1): 347-60.
223. Kahneman, D., P. Slovic, et al. (1982). Judgment Under Uncertainty: Heuristics and Biases. Cambridge, Cambridge University Press.
224. Knottnerus, J. A., and C. Van Weel (2002). General Introduction: evaluation of diagnostic procedures. In: The Evidence Base of Clinical Diagnosis. J. A. Knottnerus, editor. London, BMJ Books, pp. 1-18.
225. Kohn, M. A., E. Kwan, et al. (2005). “Prevalence of acute myocardial infarction and other serious diagnoses in patients presenting to an urban emergency department with chest pain.” J Emerg Med 29(4): 383-90.
226. Lancet (1995). “Evidence-based medicine, in its place.” Lancet 346(8978): 785.
227. Merenstein, D. (2004). “Apiece of my mind. Winners and losers.” JAMA 291(1): 15-6.
228. Newman, T. B., and M. J. Maisels (2000). “Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines.” Pediatrics 105(1 Pt 3): 242-5.
229. NIH (1997). “NIH Consensus Statement. Breast cancer screening for women ages 40-49.” NIH Consens Statement 15(1): 1-35.
230. Pantell, R. H., T. B. Newman, et al. (2004). “Management and outcomes of care of fever in early infancy.” JAMA 291(10): 1203-12.
231. Phelps, M. A., and M. A. Levitt (2004). “Pretest probability estimates: a pitfall to the clinical utility of evidence-based medicine?” Acad Emerg Med 11(6): 692-4.
232. Raiffa, H. (1968). Decision Analysis: Introductory Lectures on Choices Under Uncertainty. Reading, MA, Addison-Wesley.
233. Smith, G. C., and J. P. Pell (2003). “Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials.” BrMed J 327(7429): 1459-61.
234. Sox, C. M., T. D. Koepsell, et al. (2006). “Pediatricians’ clinical decision making: results of 2 randomized controlled trials of test performance characteristics.” Arch Pediatr Adolesc Med 160(5): 487-92.
235. Tierney, W. M., B. J. Roth, et al. (1985). “Predictors of myocardial infarction in emergency room patients.” Crit Care Med 13(7): 526-31.
236. Tversky, A., and D. Kahneman (1974). “Judgment under uncertainty: heuristics and biases.” Science 185: 1124-31.
237. US Preventive Services Task Force (2002). “Screening for prostate cancer: recommendation and rationale.” Ann Intern Med 137(11): 915-6.
238. Woolf, S. H., and J. N. George (2000). “Evidence-based medicine. Interpreting studies and setting policy.” Hematol Oncol Clin North Am 14(4): 761-84.